Urgent

Cardiac disease in pregnancy

Cardiac · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Cardiac disease is a leading cause of indirect maternal death. The haemodynamic demands of pregnancy, labour and the early postpartum period can decompensate underlying structural, ischaemic or arrhythmic conditions, requiring multidisciplinary planning.

Red flags

  • Breathlessness at rest or orthopnoea
  • Chest pain
  • Syncope or sustained arrhythmia
  • Oxygen desaturation
  • Signs of pulmonary oedema

Assessment

Differential diagnosis

  • Valvular heart disease (especially mitral stenosis)
  • Congenital heart disease
  • Cardiomyopathy including peripartum
  • Ischaemic heart disease / aortic dissection
  • Arrhythmia
  • Pulmonary hypertension

Investigations

  • ECG and echocardiography to define lesion and function
  • BNP/NT-proBNP for suspected heart failure
  • Oxygen saturation and exercise tolerance assessment
  • Chest imaging and troponin if acute presentation
  • Fetal growth surveillance given risk of restriction
  • Anticoagulation monitoring where relevant

Management

  • Risk-stratify using a recognised classification (e.g. modified WHO) ideally before pregnancy
  • Establish a multidisciplinary pregnancy heart team including cardiology, obstetrics and anaesthetics
  • Review and switch cardiac medications to pregnancy-compatible agents (stop ACE inhibitors, ARBs and most statins)
  • Manage anticoagulation carefully for mechanical valves, balancing maternal and fetal risk
  • Monitor for heart failure, arrhythmia and deterioration through pregnancy
  • Plan timing, place and mode of birth with the heart team; aim for vaginal birth in most stable lesions
  • Use controlled regional analgesia and avoid fluid overload intrapartum
  • Give cautious, slow oxytocin for the third stage and avoid ergometrine in most cardiac disease
  • Provide close monitoring in the first 24-72 hours postpartum when fluid shifts peak

Drugs & doses

Labetalol or other pregnancy-safe agents for hypertension/rate control
Low-molecular-weight heparin or adjusted warfarin for mechanical valve anticoagulation per protocol
Oxytocin by slow infusion for the third stage (avoid bolus)
Avoid ergometrine where hypertension or ischaemic risk exists

Disposition

Consultant-led multidisciplinary pregnancy heart team; deliver in a unit with cardiology and high-dependency support; closely monitor postpartum.

Complications & pitfalls

  • Heart failure and pulmonary oedema
  • Arrhythmia
  • Thromboembolism and valve thrombosis
  • Fetal growth restriction and preterm birth
  • Maternal death (notably in pulmonary hypertension)

Exam pearls

  • Pulmonary hypertension carries very high maternal mortality and pregnancy is generally advised against
  • The early postpartum period is the highest-risk time for decompensation
  • Avoid oxytocin boluses and ergometrine in significant cardiac disease
  • Mechanical valve anticoagulation choices must be individualised with the woman

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.